Plan backward from the required arrival date and identify the approvals that must happen first. The example below demonstrates dependencies only; it is not an actual LAEYO schedule or delivery commitment.
Lead time stages
Separate samples, packaging, technical/document review, any required pilot, bulk production, QC release and transport. Work may run in parallel only when its inputs and approvals allow it.
| Illustrative stage | Invented calendar-day window relative to arrival D0 | Dependency / buyer approval |
|---|---|---|
| Sample cycle | D−45 to D−35: 10 days | Example split: 3 R&D + 3 shipping + 4 buyer review; start inputs to confirm |
| Packaging preparation | D−35 to D−21: 14 days | Approved component/artwork inputs; parallel with evidence review only if accepted |
| Technical evidence / document review | D−35 to D−21: 14-day placeholder | Approved formula/use; actual study duration may be longer and override this example |
| Pilot / review if required | D−21 to D−17: 4 days | Relevant pack and evidence ready; authorize next stage |
| Production | D−17 to D−12: 5 days | Approved pilot disposition, materials and confirmed capacity |
| Final QC / release | D−12 to D−10: 2 days | Required results and authorized release |
| Transport / clearance allowance | D−10 to D0: 10 days | Released goods, booking, route and documentation ready |
What buyers should prepare
Agree the actual clock start for each activity: accepted brief and sample inputs, approved formula/pack, effective order terms, available materials and confirmed capacity are different events. LAEYO’s owner-confirmed sample R&D reference is approximately three days, excluding communication, customer confirmation waits and shipping. It is the only company duration used here; the ten-day sample cycle and every other window above are invented for explanation.
Common delays
- Formula, concentration, use or claim change: Reassess evidence, labels and process needs.
- Bottle, closure, decoration, artwork or outer-pack change: Reconfirm samples, supplier dates and validation.
- Quantity or allocation change: Recheck material/component minimums, capacity and quote.
- Late approval or failed/deferred result: Identify the affected dependency and obtain a new decision.
- Destination, mode or deadline change: Recheck classification, documents, booking and arrival assumptions.
In the illustration, the packaging and evidence branches converge at D−21. Both must be ready for the selected pilot; a delay on either can move the critical path. Actual capacity may no longer be available when approval arrives, so a delay need not shift the schedule one-for-one.
Next step
Use the factory scheduling guide for freeze-point and owner fields. Then request a project-specific review with the fixed deadline and unresolved approvals. Deposits or tentative reservations have only the rights and conditions agreed in the contract.
Next buyer action
Timeline-Sensitive Inquiry Fields
| Field | Entry |
|---|---|
| Destination market / warehouse | [Country, delivery place and market requirements] |
| Requested arrival / non-movable cutoff | [Dates; business consequence; whether flexible] |
| Product / quantity / allocation | [Format, mL, total bottles and requested lines] |
| Formula / pack / artwork status | [Versions, approvals and missing inputs] |
| Buyer review availability | [Named decision owners and agreed response targets] |
| Evidence / sample / pilot needs | [Scope, provider, expected dates and unknowns] |
| Transport and commercial conditions | [Mode/route, quote boundary and reservation terms] |
Replace every illustrative duration with confirmed project information before relying on the plan. No actual completed project schedule has been supplied here.